Work

N0675: NCCTG phase II study of temozolomide (TMZ) and everolimus (RAD001) therapy for metastatic melanoma (MM).

Year: 2010

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2010.28.15_suppl.8572

Authors: R. S. Dronca, D. G. Perez, J. Allred, W. J. Maples, E. T. Creagan, B. A. Pockaj, J. S. Kaur, T. D. Moore, B. T. Marchello, S. Markovic

Language: English

Topic: Cutaneous Melanoma Detection and Management

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2528577666

Cites:

Cited by: 3

Related to: 10